Relapsed plasmablastic lymphoma in a HIV‐negative patient: Pushing the envelope

This case emphasizes that, with the availability of novel immunotherapy agents (Daratumumab), and repurposed use of bortezomib, a patient with HIV‐negative relapsed PBL can be treated successfully and consolidated with an allogeneic haploidentical hematopoietic cell transplantation.

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Case Rep
Main Authors: Kathrotiya, Manthan, Radhakrishnan, Vivek S, Bhave, Saurabh J, Kumar, Jeevan, Roychowdhury, Mita, Arun, Indu, Das, Jayanta, Chandy, Mammen, Nair, Reena
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Case Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869339/
https://ncbi.nlm.nih.gov/pubmed/33598263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3673
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados